BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7437431)

  • 1. Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
    Cadman E; Benz C
    Biochim Biophys Acta; 1980 Oct; 609(3):372-82. PubMed ID: 7437431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
    Plagemann PG; Behrens M; Abraham D
    Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
    Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
    Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in de novo pyrimidine biosynthesis during uridine reversal of pyrazofurin-inhibited DNA synthesis.
    Ringer DP; Howell BA; Etheredge JL
    J Biochem Toxicol; 1991; 6(1):19-27. PubMed ID: 1880786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).
    Peters GJ; Sharma SL; Laurensse E; Pinedo HM
    Invest New Drugs; 1987; 5(3):235-44. PubMed ID: 2822596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD; Smith PA; Levy EJ; Handschumacher RE
    Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of de novo pyrimidine nucleotide and DNA synthesis and growth of cultured Novikoff rat hepatoma cells and other cell lines by pyrazofurin (NSC 143095).
    Plagemann PG; Behrens M
    Cancer Res; 1976 Oct; 36(10):3807-12. PubMed ID: 182363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells.
    Karle JM; Anderson LW; Cysyk RL
    J Biol Chem; 1984 Jan; 259(1):67-72. PubMed ID: 6323418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage of circulating pyrimidine nucleosides in the rat.
    Moyer JD; Oliver JT; Handschumacher RE
    Cancer Res; 1981 Aug; 41(8):3010-7. PubMed ID: 7248957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
    Karle JM; Cowan KH; Chisena CA; Cysyk RL
    Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide pools in Novikoff rat hepatoma cells growing in suspension culture. 3. Effects of nucleosides in medium on levels of nucleotides in separate nucleotide pools for nuclear and cytoplasmic RNA synthesis.
    Plagemann PG
    J Cell Biol; 1972 Jan; 52(1):131-46. PubMed ID: 4331295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
    Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
    Karle JM; Cysyk RL
    Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 2-beta-D-ribofuranosylthiazole-4-carboxamide on uptake of nucleosides by cultured L1210 cells.
    Karle JM; Monks A; Wolfe RM; Cysyk RL
    Cancer Lett; 1984 Aug; 24(1):11-8. PubMed ID: 6498794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
    Moyer JD; Malinowski NM; Treanor SP; Marquez VE
    Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 6-azauridine and pyrazofurin on fibrinolysis by L1210 leukemic cells.
    Novak JF
    Oncology; 1982; 39(2):118-25. PubMed ID: 6174911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uridine as the only alternative to pyrimidine de novo synthesis in rat T lymphocytes.
    Bismuth G; Thuillier L; Perignon JL; Cartier PH
    FEBS Lett; 1982 Nov; 148(1):135-9. PubMed ID: 6983457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
    Chen SF; Ruben RL; Dexter DL
    Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.